DPPX-Antibody-Associated Encephalitis Induced by Immune Checkpoint Inhibitor Treatment for Advanced Hepatocellular Carcinoma

참고문헌 (9)

1. Nersesjan V, "Autoimmune encephalitis related to cancer treatment with immune checkpoint inhibitors : a systematic review", Neurology, 97, pp.e191~e202 (2021)
2. Velasco R, "Encephalitis induced by immune checkpoint inhibitors : a systematic review", JAMA Neurol, 78, pp.864~873 (2021)
3. Vogrig A, "Central nervous system complications associated with immune checkpoint inhibitors", J Neurol Neurosurg Psychiatry, 91, pp.772~778 (2020)
4. Yshii LM, "Inflammatory CNS disease caused by immune checkpoint inhibitors : status and perspectives", Nat Rev Neurol, 13, pp.755~763 (2017)
5. Meyers BM, "The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma–A systematic review", Cancer Treat Rev, 118, pp.102584~ (2023)
6. Marini A, "Neurologic adverse events of immune checkpoint inhibitors : a systematic review", Neurology, 96, pp.754~766 (2021)
7. Farina A, "Neurological adverse events of immune checkpoint inhibitors : an update of clinical presentations, diagnosis, and management", Rev Neurol(Paris), 179, pp.506~515 (2023)
8. Boronat A, "Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4. 2 potassium channels", Ann Neurol, 73, pp.120~128 (2013)
9. Williams TJ, "Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer", JAMA Neurol, 73, pp.928~933 (2016)

관련 논문AI추천